U.S. Luxury Stock News

OTCPK:GLAS.F
OTCPK:GLAS.FPersonal Products

Glass House Brands (OTCPK:GLAS.F) Q3 Loss Renews Doubts On Path To Sustainable Profitability

Glass House Brands (OTCPK:GLAS.F) has just posted a mixed FY 2025 picture, with Q3 revenue of US$38.4 million and a basic EPS loss of US$0.19, set against trailing 12 month revenue of US$196.2 million and a basic EPS loss of US$0.23. Over recent quarters, the company has seen revenue range from US$53.0 million in Q4 2024 to US$59.9 million in Q2 2025, while basic EPS has swung between a profit of US$0.10 in Q4 2024 and a loss of US$0.19 in Q3 2025. This keeps the focus firmly on how...
NYSE:INSP
NYSE:INSPMedical Equipment

Inspire Medical Systems Governance Vote Arrives As Shares Trade Below Targets

Inspire Medical Systems (NYSE:INSP) has put forward a proposal to amend its Certificate of Incorporation. Shareholders are scheduled to vote on the amendment at the upcoming annual general meeting. The change targets the company’s core governance framework, which may influence how future decisions are approved and overseen. The vote comes at a time when Inspire Medical Systems shares trade around $51.41, with returns showing an 8.8% decline over the past week and 11.8% over the past month...
NYSE:OMC
NYSE:OMCMedia

Assessing Omnicom Group (OMC) Valuation After The Interpublic Acquisition Announcement

Omnicom Group overview Omnicom Group (OMC) has drawn investor attention after recent trading left the shares around $75.74, with returns negative over the past month, past 3 months, year to date, and past year. See our latest analysis for Omnicom Group. Recent trading reflects fading momentum, with a 30 day share price return showing a 6.20% decline and a 1 year total shareholder return showing a 2.98% decline, despite a positive 5 year total shareholder return of 21.77%. If you are weighing...
NYSE:ALB
NYSE:ALBChemicals

Is It Too Late To Consider Albemarle (ALB) After A 144% One-Year Surge?

Wondering if Albemarle at a last close of US$181.39 still offers value, or if the best gains are already in the rearview mirror. The stock has returned 9.4% over the last 7 days, 2.2% over 30 days, 26.0% year to date, and 143.8% over the past year, while the 3 year and 5 year returns sit at negative 15.5% and 31.7% respectively. Those swings in performance set the scene for a closer look at what might be driving sentiment, from changing expectations around Albemarle's end markets to shifting...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Braze (BRZE) Q4 Revenue Near US$205 Million Reinforces Growth Narrative Despite Ongoing Losses

Braze (BRZE) just closed out FY 2026 with fourth quarter revenue of US$205.2 million and a basic EPS loss of US$0.29, while the trailing twelve months show revenue of US$738.2 million and a full year basic EPS loss of US$1.22. Over recent periods, the company has seen quarterly revenue move from US$160.4 million in Q4 FY 2025 to US$205.2 million in Q4 FY 2026, with basic EPS losses in those quarters of US$0.17 and US$0.29 respectively. With losses still weighing on margins, the latest numbers...
NasdaqCM:VELO
NasdaqCM:VELOMachinery

Velo3D (VELO) Quarterly Loss Of US$11.8 Million Tests Bullish Profitability Narratives

Velo3D (VELO) has released its latest FY 2025 figures, reporting Q3 revenue of US$13.6 million and a basic EPS loss of US$0.69, alongside net income excluding extra items of a US$11.8 million loss. This keeps the focus firmly on profitability rather than the top line alone. Over recent quarters, the company’s revenue moved from US$8.2 million in Q3 2024 to US$13.6 million in Q3 2025, while basic EPS shifted from a loss of US$37.54 to a loss of US$0.69 as net losses moved from US$23.1 million...
NYSE:HUN
NYSE:HUNChemicals

A Look At Huntsman (HUN) Valuation After Hungary Capacity Expansion

What Huntsman’s Hungary expansion means for the stock Huntsman (HUN) has drawn fresh attention after opening an expanded Performance Products facility in Petfurdo, Hungary. The project increases global capacity with support from a local government investment grant and targets polyurethane, coatings, metalworking and electronics customers. See our latest analysis for Huntsman. The Hungary expansion comes as Huntsman’s share price has climbed 21.39% year to date and 24.95% over 90 days, while...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Its Recent Share Price Pullback

This article examines whether Natera, at around US$197 a share, still aligns with its underlying worth or whether expectations have already been priced in. The stock has delivered a 31.7% return over the last year and a large 3-year return of about 3.5x, even though the year-to-date move is a 13.8% decline and the last 30 days show a 5.7% decline. Recent coverage around Natera has focused on its position in the pharmaceuticals and biotech space, with investors closely watching how its...
NYSE:STUB
NYSE:STUBEntertainment

Assessing StubHub Holdings (STUB) Valuation After Recent Share Price Strength And Ongoing Losses

StubHub Holdings (STUB) has drawn attention after recent trading, with the share price closing at US$6.87 and showing a return of about 4.2% over the latest session. See our latest analysis for StubHub Holdings. The latest 1 day share price return of 4.3% comes after a weaker patch. The 30 day share price return of 26.2% and year to date share price return of 51.9% both point to fading momentum rather than a quick reversal. If this kind of volatility has you looking at alternatives, it could...
NYSE:NOAH
NYSE:NOAHCapital Markets

Noah Holdings (NYSE:NOAH) Margin Improvement Challenges Cautious Narratives After FY 2025 Results

Noah Holdings (NYSE:NOAH) has wrapped up FY 2025 with fourth quarter revenue of C¥733.2 million and net income, excluding extra items, of C¥12.8 million, setting the stage for investors to reassess the story at a share price of US$11.33. Over the past few quarters, the company has seen quarterly revenue move from C¥651.9 million in Q4 2024 to C¥614.6 million, C¥629.5 million and C¥632.9 million in the first three quarters of 2025. Over the same period, basic EPS stepped from C¥1.56 in Q4 2024...
NYSE:HLT
NYSE:HLTHospitality

Is It Too Late To Consider Hilton (HLT) After Its Strong Multi Year Share Price Run?

If you are wondering whether Hilton Worldwide Holdings at around US$303 per share offers fair value or is pricing in too much optimism, this breakdown will help you frame the stock through several valuation lenses. The share price closed at US$303.16, with returns of 2.9% over 7 days, a 2.8% decline over 30 days, 3.5% year to date, 29.4% over 1 year, 125.0% over 3 years and 154.0% over 5 years. This raises clear questions about what is already reflected in the price. Recent coverage has...
NasdaqGM:EDAP
NasdaqGM:EDAPMedical Equipment

Persistent €19.6 Million Annual Loss Tests EDAP TMS (NasdaqGM:EDAP) Growth Narrative After Q3 Results

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...
NYSE:WDH
NYSE:WDHInsurance

Waterdrop (NYSE:WDH) Margin Expansion Reinforces Bullish AI Efficiency Narrative

Waterdrop (NYSE:WDH) has put solid numbers on the table for FY 2025 so far, with third quarter revenue of ¥974.9 million and basic EPS of ¥0.44, alongside trailing 12 month EPS of ¥1.40 supported by net income of ¥506.4 million on revenue of ¥3.25 billion. Over recent quarters the company has seen revenue move from ¥676.2 million in Q2 2024 to ¥753.7 million in Q1 2025 and then to ¥974.9 million in Q3 2025. Basic EPS progressed from ¥0.24 in Q2 2024 to ¥0.30 in Q1 2025 and ¥0.44 in Q3 2025,...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

FDA Warning On Anktiva Puts ImmunityBio Growth Story Under Scrutiny

The U.S. FDA has issued a warning letter to ImmunityBio over allegedly false and misleading promotional claims for its bladder cancer drug Anktiva. The letter focuses on how Anktiva has been marketed to healthcare professionals and patients, and requests corrective action from the company. This regulatory action introduces additional marketing and compliance risk for ImmunityBio at a time when its drug portfolio is gaining wider attention. For investors following ImmunityBio, ticker...
NasdaqGS:EEFT
NasdaqGS:EEFTDiversified Financial

Is It Time To Revisit Euronet Worldwide (EEFT) After Its Sharp One Year Share Price Slump?

Wondering whether Euronet Worldwide at a last close of US$67.11 still reflects its true worth, or if the market is mispricing the stock. The share price has been under pressure, with returns of a 0.8% decline over 7 days, a 4.8% decline over 30 days, a 9.4% decline year to date, and a 38.8% decline over the past year, adding to an already weak 3-year and 5-year picture of 38.5% and 51.5% declines. Recent news coverage has focused on Euronet Worldwide's position within the Diversified...
NYSE:KBH
NYSE:KBHConsumer Durables

KB Home (KBH) Margin Squeeze In Q1 2026 Reinforces Bearish Profitability Narrative

KB Home Q1 2026: Earnings slip as margins come under pressure KB Home (KBH) opened fiscal 2026 with Q1 revenue of US$1,077.0 million and basic EPS of US$0.53, alongside net income of US$33.4 million as investors weigh how these figures fit into the broader housing cycle. Over recent quarters the company has seen quarterly revenue move from US$1,391.8 million in Q1 2025 to a peak of US$1,999.9 million in Q4 2024 before easing back to US$1,077.0 million in the latest quarter. Quarterly basic...
NYSE:ACM
NYSE:ACMConstruction

AECOM’s San Diego School Deal Adds Support To Undervalued Share Story

AECOM (NYSE:ACM) has extended its multi decade partnership with San Diego Unified School District. The company has been selected as prime consultant to support school modernization, safety, security, and sustainability upgrades. The new role covers projects such as new classrooms, safety and security initiatives, and sustainability improvements across the district. AECOM operates at the intersection of infrastructure, buildings, and environmental services, and this new prime consultant role...
NasdaqCM:PAYS
NasdaqCM:PAYSDiversified Financial

Paysign (PAYS) Margin Expansion To 9.2% Reinforces Bullish Quality Narrative

Paysign (PAYS) has wrapped up FY 2025 with fourth quarter revenue of about US$22.8 million and basic EPS of US$0.02, set against trailing twelve month revenue of US$82.0 million and EPS of US$0.14 that follows reported earnings growth of 97.9% over the past year. The company has seen revenue move from US$56.5 million on a trailing basis in Q3 2024 to US$82.0 million by Q4 2025, while trailing EPS has shifted from US$0.15 to US$0.14. This sets up a story where investors are weighing 20.3%...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

Does FuboTV’s (FUBO) Odd Split Ratio Hint At A Deeper Capital Structure Reset?

FuboTV Inc. completed a 1-for-12.00048 stock split on March 24, 2026, rebalancing its share count and per-share price structure. This unusually granular split ratio highlights management’s focus on aligning FuboTV’s capital structure with listing requirements and investor accessibility objectives. Next, we’ll examine how this unconventional stock split ratio could influence FuboTV’s investment narrative and appeal to different investor groups. We've uncovered the 12 dividend fortresses...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Deepens Pharma Role With Daiichi Sankyo Oncology Partnership

Tempus AI and Daiichi Sankyo have entered into a collaboration to use Tempus' multimodal AI models in an oncology drug program. The partnership focuses on improving patient stratification and clinical development for an antibody drug conjugate. Tempus' real world oncology database and AI technology will be integrated directly into a late stage drug program. For investors tracking NasdaqGS:TEM, this agreement indicates that Tempus AI is operating increasingly as a platform partner to large...
NYSE:SPXC
NYSE:SPXCMachinery

A Look At SPX Technologies (SPXC) Valuation As Shares Trade Near Narrative Fair Value

Event context and recent performance SPX Technologies (SPXC) has drawn investor attention after recent share price moves, with the stock last closing at US$201.27 and showing mixed short term returns over the past week and month. See our latest analysis for SPX Technologies. That short term softness, including a 1 month share price return of 15.14% decline, sits alongside a much stronger long term picture. A 1 year total shareholder return of 47.91% suggests earlier optimism about growth or...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Is It Time To Reassess Duolingo (DUOL) After Its 71% Share Price Slide?

If you are wondering whether Duolingo's current share price reflects its true worth, the recent performance gives plenty to think about. The stock recently closed at US$97.68, with returns of a 6.4% decline over 7 days, a 13.5% decline over 30 days, a 44.7% decline year to date and a 71.3% decline over the past year, which has changed how some investors may be assessing its risk and potential. Recent coverage has focused on Duolingo's position in consumer services and how sentiment around...
NYSE:BANC
NYSE:BANCBanks

Did Banc of California’s (BANC) Note Redemption and Buyback Extension Just Redefine Its Capital Playbook?

In March 2026, Banc of California announced plans to redeem the entire US$385,000,000 of 3.25% Fixed-to-Floating Rate Subordinated Notes due 2031, while its Board extended the existing stock repurchase program through March 16, 2027 with about US$83,000,000 remaining for future buybacks. Together, the planned note redemption and extended buyback program underscore how management is actively reshaping the balance sheet and capital return mix using its current liquidity and capital...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines’ US$180.4m NASA Win And What It Means For LUNR

Intuitive Machines has been awarded a new $180.4 million NASA contract to deliver a lunar rover and multiple payloads to the Lunar South Pole. The mission will use the company’s larger class Nova D lunar lander and represents its most complex mission to date. The project includes participation from the Australian Space Agency and commercial partners, expanding international and commercial ties. For investors watching Intuitive Machines (NasdaqGM:LUNR), this contract provides an additional...